more_reports

3D Mapping Program Targets Historic Underground Zones Ahead of 10,000-Foot Drill Campaign

  ()
Giant Mining Corp. (CSE: BFG; OTC: BFGFF; FWB: YW5) engaged UAS Inc. to complete a high-resolution underground LiDAR survey at its Majuba Hill project in Nevada.

Gold Co. Uncovers High-Grade Gold in Brazil, Issues Shares in Bought Deal

  ()
Cabral Gold Inc. (CBR:TSX.V; CBGZF:OTCMKTS) raised CA$20M to expand drilling in Brazil's Tapajos, accelerating resource growth across the district.
Tags: Gold

A Major Currency Event is Unfolding

Contributed Opinion
  ()
With Operation Epic Fury still on everyone's minds, Barry Dawes of Martin Place Securities shares his thoughts on the market and where currencies are headed.

Ngaere-2 Well Beats Expectations, Tariki Gas Storage Offer Imminent

Research Report
  ()
Auctus Advisors raised its target price on New Zealand Energy Corp. (NZ:TSX.V; NZERF:OTCQX) after the Ngaere-2 well recompletion delivered 300 bbl/d, exceeding expectations.

Defense Tech Firm Advances GPS-Denied Navigation Breakthrough in Ukraine

  ()
Sparc AI Inc. (SPAI:CSE; SPAIF:OTCQB; 5OVO:Frankfurt) appoints an agent to work in Ukraine. Read why one analyst says SPAI has "decisive operational advantage."

Biotech Company Uncovers Breakthrough Canine Arthritis Treatment

  ()
Israeli co. Can-Fite BioPharma Ltd. (CANF:NYSEAmerican) teamed up with Vetbiolix to trial Piclidenoson for dogs, with Phase 2 results due Q3 2026. Yet, one analyst still rates the stock as a Hold. Read on to see why.

Tech Company Attracts Breakthrough Billion-Dollar Activist Investment

  ()
An activist investor, Elliott Investment Management, has taken a billion-dollar stake in AI powerhouse Synopsys Inc. (SNPS:NASDAQ). See why analysts see the company finding success in this explosive market.

When the World's on Fire, We Buy

Contributed Opinion
  ()
Stephen McBride of RiskHedge talks about his strategy for buying in a tumultuous world.

Uranium Company Advances Major Supply Breakthrough via Largest Resource in US

  ()
Uranium Energy Corp. (UEC:NYSE AMERICAN) restarts Wyoming mine, pursues conversion facility, and scales U.S. production assets amid domestic uranium shortage.
Tags: Uranium

Contango ORE, Dolly Varden Complete 'Transformative' Merger

  ()
Contango ORE Inc (CTGO:NYSEA) and Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) successfully complete what one expert calls a transformative merger.

Trumped!

Contributed Opinion
  ()
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market, and shares one copper stock on his list.

Energy Co. Begins KW1X Production Testing in Namibia: Six Zones, 346 MMbbl Upside and a 349% Target Return

Research Report
  ()
Research Capital reaffirmed its rating and target on Reconnaissance Energy Africa Ltd. (RECO:TSXV; RECAF:OTCQX; 0XD:FSE) as production testing kicked off at the KW1X well in Namibia.

Copper and Titanium Mineralization Observed Across Broad Intervals in First Phase of U.S. Drill Program

  ()
Green Bridge Metals Corp. (GRBM:CSE; GBMCF:OTC; J48:FWB) reported visual sulphide mineralization across three initial drill holes at its Titac project in Minnesota.

Royalty Presents Another Hurdle for Barrick

Contributed Opinion
  ()
Global Analyst Adrian Day updates us on developments at a couple of companies on his list.

High-Grade Gold Intercepts and Expanding Resource Potential Highlight Major Northern District Drill Campaign

  ()
B2Gold Corp. (BTG:NYSE; BTO:TSX; B2G:NSX) reported high-grade drill results and expanded resource potential from its 2025 Back River Gold District program.
Tags: Gold

Biotech Price Target Raised on Strong FSHD and DM1 siRNA Data

Research Report
  ()
Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising Phase 1/2 data for siRNA candidates SRP-1001 in FSHD and SRP-1003 in DM1, citing superior muscle concentration and a clean safety profile versus rival programs from Novartis and Dyne Therapeutics.

Expert Investing Ideas

"TORR nearly doubled the size of the Sonic copper-gold soil anomaly."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"As of early 2026, GOT holds more than $50M in cash."

–John Newell, John Newell & Associates


"WEX is continuing to progress along its two-pronged strategy."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"Drilling is ongoing at DRY's Pearl zone as well as the Hyndman target."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"We are initiating coverage on ATCX with a Buy rating."

–Jake Sekelsky, Alliance Global Partners


"WRLG's Rowan results add confidence in the project."

–Jeff Clark, TheGoldAdvisor.com


"LGD offers a compelling asymmetric opportunity."

–Lauren McConnell, Paradigm Capital


Streetwise Reader Icon Streetwise Key Charts
Gold Silver Copper Zinc Oil Gas Natural Gas Battery Metals Coal Uranium Pharma Biotech & Life Sci

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

Tungsten Outpaces Gold and Copper as Global Supply Tightens

  ()
Allied Critical Metals Inc. (ACM:CSE; ACMIF:OTCQB; 0VJ0:FSE) and American Tungsten Corp. (TUNG:CSE; TUNGF:OTCQB; RK9:FSE) are advancing projects as tungsten prices rise 557% amid global supply constraints.

Explorer With High-Grade Gold in New Zealand Launches OTCQB Trading

  ()
KO Gold Inc.'s (KOG:CSE) shares begin trading on the OTCQB Venture Market. Read why one analyst says the stock has upside potential.
Tags: Gold

Canadian Gold Co. Unlocks High-Grade Gold Potential in Colombia

  ()
Tiger Gold Corp. (TIGR:TSXV) advanced drilling at Colombia's Quinchia project while gaining DTC approval, boosting liquidity, and expanding investor access.
Tags: Gold

Massachusetts Biotech Co. Finds High-Potential Muscle Treatment Breakthrough

  ()
Sarepta Therapeutics Inc.'s (SRPT:NASDAQ) early results reveal dose-dependent drug exposure and significant biomarker reductions for forms of muscular dystrophy.

First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands

  ()
Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option.